{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:32:12Z","timestamp":1789648332625,"version":"4.0.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA106672"],"award-info":[{"award-number":["P30CA106672"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.clbc.2026.01.013","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:47:25Z","timestamp":1770943645000},"page":"109-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Locoregional Nodal Status at Initial Presentation on Ultrasound (US) and Positron Emission Tomography\/Computerized Tomography (18F-FDG PET\/CT) in Inflammatory Breast Cancer (IBC) Patients is Predictive of Overall Survival"],"prefix":"10.1016","volume":"26","author":[{"given":"Andrea","family":"Tenreiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Whitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Kai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Guirguis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miral","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Lucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy A.","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0356-498X","authenticated-orcid":false,"given":"Huong","family":"Le-Petross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clbc.2026.01.013_bib0001","first-page":"291","article-title":"Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program","volume":"74","author":"Levine","year":"1985","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2026.01.013_bib0002","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10549-007-9671-z","article-title":"Inflammatory breast cancer: PET\/CT, MRI, mammography, and sonography findings","volume":"109","author":"Yang","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2026.01.013_bib0003","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2967\/jnumed.115.158287","article-title":"18F-FDG PET\/CT to predict response to neoadjuvant chemotherapy and prognosis in inflammatory breast cancer","volume":"56","author":"Champion","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clbc.2026.01.013_bib0004","first-page":"93","article-title":"The Eighth edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clbc.2026.01.013_bib0005","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1002\/cncr.24534","article-title":"18F-fluorodeoxyglucose positron emission tomography\/computed tomography (FDG-PET\/CT) imaging in the staging and prognosis of inflammatory breast cancer","volume":"115","author":"Alberini","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2026.01.013_bib0006","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1148\/rg.2021210053","article-title":"Imaging updates to breast cancer lymph node management","volume":"41","author":"Chung","year":"2021","journal-title":"Radiographics"},{"key":"10.1016\/j.clbc.2026.01.013_bib0007","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1055\/s-0035-1555872","article-title":"Assessment of ultrasound features predicting axillary nodal metastasis in breast cancer: the impact of cortical thickness","volume":"1","author":"Stachs","year":"2015","journal-title":"Ultrasound Int Open"},{"key":"10.1016\/j.clbc.2026.01.013_bib0008","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4137\/BCBCR.S11215","article-title":"Axillary ultrasound for breast cancer staging: an attempt to identify clinical\/histopathological factors impacting diagnostic performance","volume":"7","author":"Ertan","year":"2013","journal-title":"Breast Cancer (Auckl)"},{"issue":"1","key":"10.1016\/j.clbc.2026.01.013_bib0009","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jss.2013.03.068","article-title":"Axillary ultrasound in patients with clinically node-negative breast cancer: which features are predictive of disease?","volume":"184","author":"Elmore","year":"2013","journal-title":"J Surg Res"},{"key":"10.1016\/j.clbc.2026.01.013_bib0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.1809","article-title":"Comparison of survival outcomes among patients with breast cancer with distant vs ipsilateral supraclavicular lymph node metastases","volume":"4","author":"Pan","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.clbc.2026.01.013_bib0011","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2214\/AJR.17.18295","article-title":"Axillary ultrasound identifies residual nodal disease after chemotherapy: results from the American College of Surgeons Oncology Group Z1071 Trial (alliance)","volume":"210","author":"Le-Petross","year":"2018","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"10.1016\/j.clbc.2026.01.013_bib0012","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1245\/s10434-022-12144-5","article-title":"Long-term oncologic outcomes in patients with inflammatory breast cancer with supraclavicular nodal involvement","volume":"29","author":"Cobb","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2026.01.013_bib0013","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13000-022-01236-1","article-title":"Breast cancer combined with contralateral neck lymph node metastasis: a case report","volume":"17","author":"Zhong","year":"2022","journal-title":"Diagn Pathol"},{"issue":"1","key":"10.1016\/j.clbc.2026.01.013_bib0014","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1186\/bcr2225","article-title":"Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer: analysis of 2,014 IBC patient cases from the California Cancer Registry","volume":"11","author":"Zell","year":"2009","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2026.01.013_bib0015","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology: breast cancer. Available at: NCCN.org. Accessed: November 17, 2025."},{"issue":"13","key":"10.1016\/j.clbc.2026.01.013_bib0016","doi-asserted-by":"crossref","first-page":"8610","DOI":"10.1245\/s10434-021-10148-1","article-title":"Contralateral axillary metastasis in patients with inflammatory breast cancer","volume":"28","author":"Postlewait","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"5 Suppl","key":"10.1016\/j.clbc.2026.01.013_bib0017","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/j.jacr.2022.02.010","article-title":"ACR appropriateness criteria\u00ae imaging of the axilla","volume":"19","author":"Le-Petross","year":"2022","journal-title":"J Am Coll Radiol"},{"issue":"9","key":"10.1016\/j.clbc.2026.01.013_bib0018","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1007\/s00259-024-06696-9","article-title":"Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET\/CT in no special type breast cancer (endorsed by the ACR, ESSO, ESTRO, EUSOBI\/ESR, and EUSOMA)","volume":"51","author":"Vaz","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.clbc.2026.01.013_bib0019","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.clbc.2026.01.013_bib0020","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.7863\/ultra.33.6.1013","volume":"33","author":"Sohn","year":"2014","journal-title":"J Ultrasound Med"},{"issue":"10","key":"10.1016\/j.clbc.2026.01.013_bib0021","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1245\/s10434-017-5952-x","article-title":"Improved locoregional control in a contemporary cohort of nonmetastatic inflammatory breast cancer patients undergoing surgery","volume":"24","author":"Rosso","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2026.01.013_bib0022","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/jbi\/wbad031","article-title":"Comparison of diagnostic sensitivity and procedure-related pain of concurrent ultrasound-guided fine-needle aspiration and core-needle biopsy of axillary lymph nodes in patients with suspected or known breast cancer","volume":"5","author":"Winkler","year":"2023","journal-title":"J Breast Imaging"},{"issue":"2","key":"10.1016\/j.clbc.2026.01.013_bib0023","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10549-023-07063-2","article-title":"Diagnostic value of contrast-enhanced ultrasound for sentinel lymph node metastasis in breast cancer: an updated meta-analysis","volume":"202","author":"Liu","year":"2023","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.clbc.2026.01.013_bib0024","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1245\/s10434-013-3229-6","article-title":"Value of preoperative ultrasound-guided axillary lymph node biopsy for preventing completion axillary lymph node dissection in breast cancer: a systematic review and meta-analysis","volume":"21","author":"Diepstraten","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2026.01.013_bib0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10549-010-0771-9","article-title":"The use of FDG-PET in assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature","volume":"123","author":"Peare","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2026.01.013_bib0026","article-title":"Comparison of the performance of [18F]-FDG PET\/CT and [18F]-FDG PET\/MRI for lymph node metastasis in breast cancer: a systematic review and meta-analysis","volume":"20","author":"Han","year":"2024","journal-title":"Curr Med Imaging"},{"issue":"1","key":"10.1016\/j.clbc.2026.01.013_bib0027","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2967\/jnumed.112.106864","article-title":"18F-FDG PET\/CT in staging patients with locally advanced or inflammatory breast cancer: comparison to conventional staging","volume":"54","author":"Groheux","year":"2013","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.clbc.2026.01.013_bib0028","first-page":"885","article-title":"Procedure guideline for tumor imaging with 18F-FDG PET\/CT 1.0","volume":"47","author":"Delbeke","year":"2006","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.clbc.2026.01.013_bib0029","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00259-013-2595-4","article-title":"\u00b9\u2078F-FDG PET\/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorations","volume":"41","author":"Cochet","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.clbc.2026.01.013_bib0030","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejso.2012.10.012","article-title":"Diagnostic performance of fluorodeoxyglucose-positron emission tomography\/computed tomography combined with ultrasonography-guided fine needle aspiration cytology for identifying axillary lymph node status in patients with breast cancer","volume":"39","author":"Machida","year":"2013","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2026.01.013_bib0031","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10549-010-1324-y","article-title":"Inflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancer","volume":"129","author":"Schairer","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"10.1016\/j.clbc.2026.01.013_bib0032","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1245\/s10434-025-17406-6","article-title":"A multi-institutional analysis of contralateral axillary metastases: advanced local-regional disease divergent from stage IV breast cancer","volume":"32","author":"Flanagan","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2026.01.013_bib0033","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.54506","article-title":"Trends in guideline-concordant care for inflammatory breast cancer","volume":"8","author":"Tadros","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.clbc.2026.01.013_bib0034","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/jamasurg.2023.2150","article-title":"Locoregional recurrence patterns in patients with different molecular subtypes of breast cancer","volume":"158","author":"Cheun","year":"2023","journal-title":"JAMA Surg"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926000133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926000133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:15:30Z","timestamp":1776467730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820926000133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1526820926000133"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2026.01.013","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Locoregional Nodal Status at Initial Presentation on Ultrasound (US) and Positron Emission Tomography\/Computerized Tomography (18F-FDG PET\/CT) in Inflammatory Breast Cancer (IBC) Patients is Predictive of Overall Survival","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2026.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}